IP Verse

Boehringer Ingelheim Pharma patent opposition analysis

Get complete Patent Opposition Report for Boehringer Ingelheim Pharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Boehringer Ingelheim Pharma

Explore patent oppositions filed by Boehringer Ingelheim Pharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3219328	Human Anti-Il-23 Antibodies, Compositions, Method And Uses	JANSSEN BIOTECH	Mar 17, 2021
EP2634243	Improved Process For The Culturing Of Cells	DPX	Jun 5, 2018
EP2634242	Improved Process For The Culturing Of Cells	DPX	Jan 4, 2018
EP2634250	Improved Process For The Culturing Of Cells	DPX	Jan 4, 2018

Latest patents of Boehringer Ingelheim Pharma opposed by its competitors

Explore Boehringer Ingelheim Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP2397142	Jul 27, 2022	Use Of Dpp Iv Inhibitors	5
EP2152341	Dec 11, 2019	Atomizer, And Filter	2
EP2433665	Aug 7, 2019	Inhaler And Sieve For An Inhaler	1
EP1940349	Feb 14, 2018	Aerosol Formulation For The Inhalation Of Beta Agonists	1

Top competitors of Boehringer Ingelheim Pharma

DPX

DSM ASSETS

PATHEON I